Johannes Breedt

Summary

Publications

  1. pmc Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam
    Johannes Breedt
    Eugene Marais Hospital, Les Marais, Pretoria, Republic of South Africa
    Antimicrob Agents Chemother 49:4658-66. 2005
  2. doi request reprint Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms
    Martin E Stryjewski
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Clin Infect Dis 46:1683-93. 2008
  3. doi request reprint Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study
    I Florescu
    Emergency Clinical Hospital, Bucharest, Romania
    J Antimicrob Chemother 62:i17-28. 2008

Collaborators

  • Evelyn J Ellis-Grosse
  • Martin E Stryjewski
  • Karl Weiss
  • M Bassetti
  • I Florescu
  • Helen Giamarellou
  • Mark Harrison
  • Donald R Graham
  • Jose Prieto
  • Fredrique Jacobs
  • Guglia Ion Dumitru
  • J H Cansen van Rensburg
  • Petre Jacob Calistru
  • Luis Ernesto Jauregi Peredo
  • Harmohinder Gogia
  • Maria Eugenia Oliva
  • Antonio Policarpo Ludvik
  • Ali El Solh
  • M Beuran
  • Christian G Schrock
  • Alberto Bedulatti Cardosa
  • Marek Ostrowski
  • G Fichev
  • Jack Cade
  • Jaime Alejandro Labarca
  • Miguel Sanchez
  • Diana Brasil Pedral Sampaio
  • K Dean Gubler
  • Markian R Bochan
  • Arnold Lentnek
  • N Dartois
  • Salah Bibi
  • Antonio Tarcisiode Faria Freire
  • Clovis Arns Da Cunha
  • A Razbadauskas
  • Claudia Gabriela Rodriguez
  • Krzysztof Kolomecki
  • Robert L Penn
  • H Gandjini
  • T Babinchak
  • Milagros Pagaduan Reyes
  • Michael J Patzakis
  • John E Mazuski
  • Manjari Joshi
  • Maria del Rayo Morfin Otero
  • William J Flynn
  • John F Reinhardt
  • G Dukart
  • R Dimov
  • Zilvinas Endzinas
  • Latha Srinath
  • Priscilla Siosan
  • C A Cooper
  • Thomas Adam Kasper
  • Maria Eugenia Valias Didier
  • Carlos Lovesio
  • M Bochan

Detail Information

Publications3

  1. pmc Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam
    Johannes Breedt
    Eugene Marais Hospital, Les Marais, Pretoria, Republic of South Africa
    Antimicrob Agents Chemother 49:4658-66. 2005
    ..Tigecycline was shown to be safe and effective for the treatment of complicated skin and skin structure infections...
  2. doi request reprint Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms
    Martin E Stryjewski
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Clin Infect Dis 46:1683-93. 2008
    ..Telavancin is an investigational, rapidly bactericidal lipoglycopeptide with a multifunctional mechanism of action...
  3. doi request reprint Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study
    I Florescu
    Emergency Clinical Hospital, Bucharest, Romania
    J Antimicrob Chemother 62:i17-28. 2008
    ..Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) are causing serious nosocomial infections. Tigecycline was evaluated in hospitalized patients with MRSA or VRE infection...